Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,272 | 71,254 | 112,956 | 90,782 | 88,079 |
| Marketable Securities | 148,820 | 153,120 | 145,964 | 161,799 | 186,033 |
| Receivables | 104,839 | 107,057 | 106,606 | 106,198 | 86,576 |
| Inventories | 130,118 | 115,628 | 112,299 | 110,067 | 109,698 |
| Income taxes - deferred | 21,115 | N/A | N/A | N/A | N/A |
| Other current assets | 18,638 | 39,965 | 36,286 | 34,984 | 33,874 |
| TOTAL | $469,802 | $487,024 | $514,111 | $503,830 | $504,260 |
| Non-Current Assets | |||||
| PPE Net | 268,971 | 266,190 | 216,496 | 217,884 | 221,866 |
| Investments And Advances | 94,944 | 146,808 | 154,327 | 142,511 | 129,253 |
| Intangibles | 231,820 | 152,323 | 154,791 | 155,747 | 157,012 |
| Other Non-Current Assets | 240,172 | 242,731 | 240,667 | 244,174 | 250,232 |
| TOTAL | $835,907 | $808,052 | $766,281 | $760,316 | $758,363 |
| Total Assets | $1,305,709 | $1,295,076 | $1,280,392 | $1,264,146 | $1,262,623 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 94,125 | 83,254 | 82,035 | 75,986 | 83,844 |
| TOTAL | $94,125 | $83,254 | $82,035 | $75,986 | $83,844 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 401,381 | 437,283 | 466,052 | 467,320 | 461,522 |
| TOTAL | $438,536 | $437,283 | $466,052 | $467,320 | $461,522 |
| Total Liabilities | $532,661 | $520,537 | $548,087 | $543,306 | $545,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,057 | 114,214 | 111,827 | 110,910 | 110,723 |
| Common Shares | 115 | 114 | 112 | 111 | 111 |
| Retained earnings | -425,101 | -398,366 | -380,713 | -375,636 | -371,265 |
| Other shareholders' equity | 952 | -2,631 | -9,826 | -7,520 | -1,777 |
| TOTAL | $773,048 | $774,539 | $732,305 | $720,840 | $717,257 |
| Total Liabilities And Equity | $1,305,709 | $1,295,076 | $1,280,392 | $1,264,146 | $1,262,623 |